Health Trials

Pregnancy and Fibrin Clot Properties

ConditionsFibrin Blood ClotPregnancyPregnancy Complicated by Cardiovascular Disorders as Postpartum Condition, Delivered During Previous Episode
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-40
SponsorJagiellonian University

About this trial

1. The structure of fibrin clot and thrombin generation may vary between trimesters of pregnancy. 2. Unfavorably altered fibrin clot properties along with enhanced thrombin generation may lead to the development of complications during pregnancy such as TE and hypertensive disorders. 3. The application of machine learning techniques may help to identify previously undetected phenotypes with increased risk of TE and hypertensive disorders during pregnancy.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • analysis of fibrin clot properties and thrombin generation

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Jagiellonian University

Lead sponsor

Source ClinicalTrials.gov